|Chemical and physical data|
|Molar mass||372.5 g·mol−1|
|3D model (JSmol)|
CUMYL-PEGACLONE (SGT-151) is a gamma-carboline based synthetic cannabinoid that has been sold as a designer drug. The gamma-carboline core structure seen in CUMYL-PEGACLONE had not previously been encountered in a designer cannabinoid, though it is similar in structure to other gamma-carboline cannabinoids disclosed by Bristol-Myers Squibb in 2001.
Sweden's public health agency classified CUMYL-PEGACLONE as a narcotic substance, on January 18, 2019.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|